Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot Study

Jing Liu, Chaoran Ji, Yueyue Li, Qiao Chen, Junnan Hu, Meng Wan, Minjuan Lin, Boshen Lin, Juan Wang, Jing Zha, Lixiang Li, Xiuli ZuoClinical 2021 · DOI

Abstract

Consecutive therapy, including amoxicillin, tetracycline, and furazolidone, achieved a good eradication rate (>90%), with desirable compliance and tolerability in difficult-to-treat H. pylori infection.
BibTeX
@inproceedings{liu2021two,
  author = {Jing Liu and Chaoran Ji and Yueyue Li and Qiao Chen and Junnan Hu and Meng Wan and Minjuan Lin and Boshen Lin and Juan Wang and Jing Zha and Lixiang Li and Xiuli Zuo},
  title = {{Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot Study}},
  booktitle = {Clinical},
  year = {2021},
  doi = {10.14309/ctg.0000000000000391},
}

Loading related content...

Figure